Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer

Abstract The left ventricular trabecular fractal dimension (LVTFD) derived from cardiac magnetic resonance reflects myocardial trabecular complexity, which is associated with cardiovascular disease risk. Baseline risk stratification of cancer therapy–related cardiac dysfunction (CTRCD) in patients w...

Full description

Saved in:
Bibliographic Details
Main Authors: Hesong Shen, Qian Xu, Chunrong Tu, Yangling Peng, Yuhang Xie, Zhiming Miao, Rui Yang, Jiuquan Zhang
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:MedComm
Subjects:
Online Access:https://doi.org/10.1002/mco2.70004
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594187253448704
author Hesong Shen
Qian Xu
Chunrong Tu
Yangling Peng
Yuhang Xie
Zhiming Miao
Rui Yang
Jiuquan Zhang
author_facet Hesong Shen
Qian Xu
Chunrong Tu
Yangling Peng
Yuhang Xie
Zhiming Miao
Rui Yang
Jiuquan Zhang
author_sort Hesong Shen
collection DOAJ
description Abstract The left ventricular trabecular fractal dimension (LVTFD) derived from cardiac magnetic resonance reflects myocardial trabecular complexity, which is associated with cardiovascular disease risk. Baseline risk stratification of cancer therapy–related cardiac dysfunction (CTRCD) in patients with breast cancer who received anthracycline is a very important clinical issue. In this study, we used the Cox model to derive and validate a new score system based on LVTFD for baseline risk stratification of CTRCD in breast cancer patients receiving anthracycline. We also compare the performance of LVTFD‐based score with the Heart Failure Association‐International Cardio‐Oncology Society (HFA‐ICOS) score using C‐index. This study enrolled 370 participants, of whom 73 participants developed CTRCD. The C‐indices of LVTFD‐based score integrating age, hypertension, previous cardiovascular disease, and maximal apical fractal dimension were higher than those of HFA‐ICOS score for stratifying CTRCD (0.834 vs. 0.642 and 0.834 vs. 0.633, respectively, in derivation and validation cohort). LVTFD‐based score can stratify the CTRCD risk, but HFA‐ICOS score cannot. The above results reveal that the LVTFD‐based score is an alternative method for baseline risk stratification of CTRCD in breast cancer who received anthracycline.
format Article
id doaj-art-0392bdb9f6404395acc60ba3bb83f5e7
institution Kabale University
issn 2688-2663
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series MedComm
spelling doaj-art-0392bdb9f6404395acc60ba3bb83f5e72025-01-20T01:45:44ZengWileyMedComm2688-26632025-01-0161n/an/a10.1002/mco2.70004Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancerHesong Shen0Qian Xu1Chunrong Tu2Yangling Peng3Yuhang Xie4Zhiming Miao5Rui Yang6Jiuquan Zhang7Department of Radiology Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital Chongqing ChinaSchool of Medicine Chongqing University Chongqing ChinaDepartment of Radiology Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital Chongqing ChinaDepartment of Radiology Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital Chongqing ChinaDepartment of Radiology Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital Chongqing ChinaDepartment of Radiology Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital Chongqing ChinaDepartment of Radiology Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital Chongqing ChinaDepartment of Radiology Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital Chongqing ChinaAbstract The left ventricular trabecular fractal dimension (LVTFD) derived from cardiac magnetic resonance reflects myocardial trabecular complexity, which is associated with cardiovascular disease risk. Baseline risk stratification of cancer therapy–related cardiac dysfunction (CTRCD) in patients with breast cancer who received anthracycline is a very important clinical issue. In this study, we used the Cox model to derive and validate a new score system based on LVTFD for baseline risk stratification of CTRCD in breast cancer patients receiving anthracycline. We also compare the performance of LVTFD‐based score with the Heart Failure Association‐International Cardio‐Oncology Society (HFA‐ICOS) score using C‐index. This study enrolled 370 participants, of whom 73 participants developed CTRCD. The C‐indices of LVTFD‐based score integrating age, hypertension, previous cardiovascular disease, and maximal apical fractal dimension were higher than those of HFA‐ICOS score for stratifying CTRCD (0.834 vs. 0.642 and 0.834 vs. 0.633, respectively, in derivation and validation cohort). LVTFD‐based score can stratify the CTRCD risk, but HFA‐ICOS score cannot. The above results reveal that the LVTFD‐based score is an alternative method for baseline risk stratification of CTRCD in breast cancer who received anthracycline.https://doi.org/10.1002/mco2.70004breast cancercardiotoxicitymagnetic resonance imaging
spellingShingle Hesong Shen
Qian Xu
Chunrong Tu
Yangling Peng
Yuhang Xie
Zhiming Miao
Rui Yang
Jiuquan Zhang
Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer
MedComm
breast cancer
cardiotoxicity
magnetic resonance imaging
title Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer
title_full Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer
title_fullStr Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer
title_full_unstemmed Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer
title_short Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer
title_sort left ventricular trabecular complexity for risk stratification of cancer therapy related cardiac dysfunction in breast cancer
topic breast cancer
cardiotoxicity
magnetic resonance imaging
url https://doi.org/10.1002/mco2.70004
work_keys_str_mv AT hesongshen leftventriculartrabecularcomplexityforriskstratificationofcancertherapyrelatedcardiacdysfunctioninbreastcancer
AT qianxu leftventriculartrabecularcomplexityforriskstratificationofcancertherapyrelatedcardiacdysfunctioninbreastcancer
AT chunrongtu leftventriculartrabecularcomplexityforriskstratificationofcancertherapyrelatedcardiacdysfunctioninbreastcancer
AT yanglingpeng leftventriculartrabecularcomplexityforriskstratificationofcancertherapyrelatedcardiacdysfunctioninbreastcancer
AT yuhangxie leftventriculartrabecularcomplexityforriskstratificationofcancertherapyrelatedcardiacdysfunctioninbreastcancer
AT zhimingmiao leftventriculartrabecularcomplexityforriskstratificationofcancertherapyrelatedcardiacdysfunctioninbreastcancer
AT ruiyang leftventriculartrabecularcomplexityforriskstratificationofcancertherapyrelatedcardiacdysfunctioninbreastcancer
AT jiuquanzhang leftventriculartrabecularcomplexityforriskstratificationofcancertherapyrelatedcardiacdysfunctioninbreastcancer